Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 15687-13-5
2. Dodeclonii Bromidum
3. Gr 412
4. Bromuro De Dodeclonio
5. Bromure De Dodeclonium
6. Gr-412
7. Xd8bu85zlk
8. Dodeclonium Bromide [inn]
9. N-[2-(4-chlorophenoxy)ethyl]-n,n-dimethyldodecan-1-aminium Bromide
10. 2-(4-chlorophenoxy)ethyl-dodecyl-dimethylazanium;bromide
11. (2-(p-chlorophenoxy)ethyl)dodecyldimethylammonium Bromide
12. Dodecloniumbromid
13. Unii-xd8bu85zlk
14. Chembl2106199
15. Schembl16049443
16. Dodeclonii Bromidum [inn-latin]
17. Dtxsid10935551
18. Chebi:135977
19. Dodeclonium Bromide [mart.]
20. Einecs 239-779-9
21. Bromure De Dodeclonium [inn-french]
22. Bromuro De Dodeclonio [inn-spanish]
23. Dodeclonium Bromide [who-dd]
24. Q27293790
25. [2-(4-chlorophenoxy)ethyl](dodecyl)dimethylazanium Bromide
26. 1-dodecanaminium, N-(2-(4-chlorophenoxy)ethyl)-n,n-dimethyl-, Bromide (1:1)
| Molecular Weight | 448.9 g/mol |
|---|---|
| Molecular Formula | C22H39BrClNO |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 15 |
| Exact Mass | 447.19036 g/mol |
| Monoisotopic Mass | 447.19036 g/mol |
| Topological Polar Surface Area | 9.2 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 300 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Dodeclonium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dodeclonium Bromide, including repackagers and relabelers. The FDA regulates Dodeclonium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dodeclonium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dodeclonium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dodeclonium Bromide supplier is an individual or a company that provides Dodeclonium Bromide active pharmaceutical ingredient (API) or Dodeclonium Bromide finished formulations upon request. The Dodeclonium Bromide suppliers may include Dodeclonium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Dodeclonium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Dodeclonium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dodeclonium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dodeclonium Bromide GMP manufacturer or Dodeclonium Bromide GMP API supplier for your needs.
A Dodeclonium Bromide CoA (Certificate of Analysis) is a formal document that attests to Dodeclonium Bromide's compliance with Dodeclonium Bromide specifications and serves as a tool for batch-level quality control.
Dodeclonium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Dodeclonium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dodeclonium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Dodeclonium Bromide EP), Dodeclonium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dodeclonium Bromide USP).
LOOKING FOR A SUPPLIER?
